Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.

from NYT > Health https://ift.tt/TdXNy37

Related Posts:

0 comments:

Post a Comment

Popular Posts